Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Cognition and Behavior

Maternal Oxycodone Treatment Results in Neurobehavioral Disruptions in Mice Offspring

Rachel E. Martin, Madison T. Green, Jessica A. Kinkade, Robert R. Schmidt, Tess E. Willemse, A. Katrin Schenk, Jiude Mao and Cheryl S. Rosenfeld
eNeuro 26 July 2021, 8 (4) ENEURO.0150-21.2021; https://doi.org/10.1523/ENEURO.0150-21.2021
Rachel E. Martin
1Christopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211
2Biomedical Sciences, University of Missouri, Columbia, MO 65211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madison T. Green
1Christopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211
2Biomedical Sciences, University of Missouri, Columbia, MO 65211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica A. Kinkade
1Christopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211
2Biomedical Sciences, University of Missouri, Columbia, MO 65211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert R. Schmidt
1Christopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211
2Biomedical Sciences, University of Missouri, Columbia, MO 65211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tess E. Willemse
1Christopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211
2Biomedical Sciences, University of Missouri, Columbia, MO 65211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Katrin Schenk
3Physics, Randolph College, Lynchburg, VA 24503
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiude Mao
1Christopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211
2Biomedical Sciences, University of Missouri, Columbia, MO 65211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl S. Rosenfeld
1Christopher S Bond Life Sciences Center, University of Missouri, Columbia, MO 65211
2Biomedical Sciences, University of Missouri, Columbia, MO 65211
4MU Institute for Data Science and Informatics, University of Missouri, Columbia, MO 65211
5Thompson Center for Autism and Neurobehavioral Disorders, University of Missouri, Columbia, MO 65211
6Genetics Area Program, University of Missouri, Columbia, MO 65211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cheryl S. Rosenfeld
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Extended Data
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Timeline for the behavioral and metabolic studies. PND = postnatal day.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Social behavior results at PND21. A, Frequency of interacting with stranger 1 in T2. B, Time spent interacting with stranger 1 in T2. C, Frequency of grooming in T2. D, Time spent grooming in T2. E, Frequency of interacting with stranger 1 in T3. F, Time spent interacting with stranger 1 in T3. G, Frequency of interacting with stranger 2 in T3. H, Time spent interacting with stranger 2 in T3. I, Frequency of grooming in T3. J, Time spent grooming in T3. The F test was used for data analysis. Treatment, sex, and treatment by sex interaction were included in the model. Treatment effects were analyzed with dam nested under treatment and used as error term. There was significant (p < 0.05) interaction between treatment and sex in frequency and time spent in grooming in T3. Significant differences are indicated in the figures. Error bars represent SEM. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group. Datapoints for all replicates who engaged in the various behaviors are shown. For grooming in T2, many of the animals in both groups did not exhibit this behavior.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Audible and ultrasonic communications at PND21. A, Fraction of calls in the ultrasonic range (above 20 kHz). B, Average power of calls below 20 kHz. C, Average power of calls above 20 kHz. D, Power of calls. The F test was used for data analysis. Treatment, sex, and treatment by sex interaction were included in the model. Treatment effects were analyzed with dam nested under treatment and used as error term. There was significant (p < 0.01) treatment effect on fraction of calls above 20 kHz as indicated in A. Error bars represent SEM. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group. Datapoints for all replicates who engaged in the various behaviors are shown. However, many of the animals in both groups did not exhibit any calls during the trial period.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Social behavior results at adulthood. A, Frequency of interacting with stranger 1 in T2. B, Time spent interacting with stranger 1 in T2. C, Frequency of grooming in T2. D, Time spent grooming in T2. E, Frequency of interacting with stranger 1 in T3. F, Time spent interacting with stranger 1 in T3. G, Frequency of interacting with stranger 2 in T3. H, Time spent interacting with stranger 2 in T3. I, Frequency of grooming in T3. J, Time spent grooming in T3. The F test was used for data analysis. Treatment, sex, and treatment by sex interaction were included in the model. Treatment effects were analyzed with dam nested under treatment and used as the error term. There were significant (p ≤ 0.05) treatment effects on frequency and time spent in interacting with Stranger 1 in T3 as indicated in E, F. Error bars represent SEM. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Audible and ultrasonic communications at adulthood. A, Fraction of calls in the ultrasonic range (above 20 kHz). B, Average power of calls below 20 kHz. C, Average power of calls above 20 kHz. D, Power of calls. The F test was used for data analysis. Treatment, sex, and treatment by sex interaction were included in the model. Treatment effects were analyzed with dam nested under treatment and used as error term. There was significant (p = 0.05) treatment effect on average power of calls as indicated in D. Error bars represent SEM. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group. As with Figures 2 and 3, datapoints for all animals who engaged in these behaviors are shown. More animals called at this age than at PND21 to allow for inferences to be made, but some animals remained silent during the trial.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Barnes maze results. A, Distance traveled. B, Travel speed. C, Number of head entries into escape hole. D, Time spent around escape hole. E, Likelihood of mice locating the correct escape hole. Distanced traveled, velocity, number of head entries into escape hole, and time spent around escape hole were analyzed as a split plot in space and time. Statistical model contained the fixed effects of treatment, sex, day, and all possible interactions with treatment, sex, and day. Latency was analyzed by using the PROC PHREG and proportional hazard ratio functions of SAS. A result <1 indicates that the treatment group is less likely to locate the correct escape hole compared with the CTL group. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    EPM results. A, Number of times spent immobile. B, Duration of time spent immobile. C, Number of entries into open arms. D, Time spent in open arms. E, Number of entries into closed arms. F, Time spent in closed arms. The F test was used for data analysis. Treatment, sex, and treatment by sex interaction were included in the model. Treatment effects were analyzed with dam nested under treatment and used as error term. There was significant (p = 0.01) treatment effect on number of times (A) and duration of time (B) spent immobile. Error bars represent SEM. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Indirect calorimetry and body mass results. A, Total distance traveled during the dark cycle. B, Percentage of time remaining still during the dark cycle. C, Food intake during the dark cycle. D, Body mass. E, Total distance traveled during the light cycle. F, Percentage of time remaining still during the light cycle. G, Food intake during the light cycle. Data were analyzed with nested design and dam as experimental unit for treatment effects with treatment, sex, light cycle, and interactions between each of these factors as main effects. To illustrate possible sex differences, data are plotted separately for each sex. Significant differences are indicated in the figures. Number of replicates tested = 13 female and 13 male mice for CTL group, 10 female and 10 male mice for OXY group.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Gene expression in hippocampal tissue. Gene expression data, as determined by qPCR assay, were normalized by using combined average dCt values of the two housekeeping genes: B2m and Rpl7 and then analyzed based on treatment, sex, and their interactions, and dam was considered the experimental unit for treatment effects. Significant differences are indicated in the figures. Gene expression patterns for: A) Htr2a; B) Oprd1; C) Oprk1; D) Oprl1; E) Oprm1; F) Slc6a4. Number of replicates tested = seven female and seven male mice for CTL group, five female and five male mice for OXY group. Additional qPCR hippocampal results are included in Extended Data Figure 9-1.

  • Figure 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 10.

    Gene expression in hypothalamic tissue. Gene expression data, as determined by qPCR assay, were normalized by using combined average dCt values of the two housekeeping genes: B2m and Rpl7 and then analyzed based on treatment, sex, and their interactions, and dam was the considered experimental unit for treatment effects. Significant differences are indicated in the figures. Gene expression patterns for: A) Avp; B) Dnmt3a; C) Oprd1; D) Oprk1; E) Oprl1; F) Oprm1. Number of replicates tested = seven female and seven male mice for CTL group, five female and five male mice for OXY group. Additional qPCR hippocampal results are included in Extended Data Figure 10-1.

  • Figure 11.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 11.

    Circos plot correlations for OXY-exposed versus CTL female mice. mixOmics R program (v6.1.1) was used to correlate Barnes maze, social, EPM, indirect calorimetry, echoMRI, and gene expression data. Correlation cutoff was set to 0.75. Red lines in the center indicate a positive correlation (A), whereas blue lines (B) indicate a negative correlation. Lines on the outside of the circle indicate whether the value was greater in CTL (blue) versus OXY (orange).

  • Figure 12.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 12.

    Circos plot correlations for OXY-exposed versus CTL groups of male mice. mixOmics R program (v6.1.1) was used to correlate Barnes maze, social, EPM, indirect calorimetry, echoMRI, and qPCR testing. Correlation cutoff was set to 0.75. Red lines in the center indicate a positive correlation (A), whereas blue lines (B) indicate a negative correlation. Lines on the outside of the circle indicate whether the value was greater in CTL (blue) versus OXY (orange).

Tables

  • Figures
  • Extended Data
    • View popup
    Table 1

    Primers used for hippocampus and hypothalamus qPCR in male and female CF1 mice offspring

    GeneForward primer (5′ to 3′)Reverse primer (5′ to 3′)Efficiency
    AvpATCTGCTGCAGCGACGAGAGTGTACCAGCCTTAGCAGCAG90.3
    B2m1CCTTCAGCAAGGACTGGTCTTTGATCACATGTCTCGATCCCAG100.3
    BdnfCGGAGAGCAGAGTCCATTCAGCTCACCTGGTGGAACTTCTTTG90.7
    Cnrip1AACACTGCAGGTCGAGAACATTTTGCCACACTGTCTCGAAGG91.3
    DATCTGGAAGATCTGCCCTGTCCCAGCACACCACGCTCAAAAT103.9
    Dnmt3aGATGAGCCTGAGTATGAGGATGGCAAGACACAATTCGGCCTGG103.6
    Dnmt3bCTGTCCGAACCCGACATAGCCCGGAAACTCCACAGGGTA96.4
    Drd1TTGAGTCCAGGGGTTTTGGGGGGCCTCTTCCTGGTCAATC99.0
    Drd2TGAACAGGCGGAGAATGGATGGTTTTGCCATTGGGCATGGT90.0
    Esr1CTTGAACCAGCAGGGTGGCAGGCTTTGGTGTGAAGGGTC100.2
    Esr2ACGAAGAGTGCTGTCCCAAGGCCAAGGGGTACATACTGGAG112.0
    GnrhCAACTGTGCTCACCAGCGGTGAGGATCATGTCCACTCTGTTT110.0
    Htr2aCACCGACATGCCTCTCCATTGGCCACCGGTACCCATACAG90.9
    Htr7GGGACCTGAGGACCACCTATCAGTGGTCACAGTTTTGTAGCA98.0
    Kiss1AGACTGTAGACCTGCCCCTTGACTGCTGGCCTGTGGAT106.7
    LeprCAGAATGACGCAGGGCTGTAGCTCAAATGTTTCAGGCTTTTGGA92.7
    Oprd1CCGTGGCCTCCGTTTTCCCAATTTGGTGTACCGGACGA95.0
    Oprk1AGTGCCACCTTCTCGCTTTGGTCTTCATCTTCGTGTATCGGA99.3
    Oprl1TCTTCGGAGCAGGAGCTAGGGCCACTCAGTACAGTTCCTCC105.4
    Oprm1CATGGCCCTCTATTCTATCGTGTCCACGTTCCCATCAGGTAGTT99.4
    OxtrGTCTGGTCAAATACTTGCAGGTCGCGCAGCGAGAAAATGTG97.6
    Rpl7AGCTGGCCTTTGTCATCAGAAGACGAAGGAGCTGCAGAACCT96.1
    Slc6a4CTCCGCAGTTCCCAGTACAAGCACGGCATAGCCAATGACAGA108.5

Extended Data

  • Figures
  • Tables
  • Extended Data Figure 9-1

    Additional gene expression in hippocampal tissue not included in Figure 9. Gene expression data, as determined by qPCR assay, were normalized by using combined average dCt values of the two housekeeping genes: B2m and Rpl7 and then analyzed based on treatment, sex, and their interactions, and dam was considered the experimental unit for treatment effects. Number of replicates tested = seven female and seven male mice for CTL group, five female and five male mice for OXY group. Download Figure 9-1, TIF file.

  • Extended Data Figure 10-1

    Additional gene expression in hypothalamic tissue not included in Figure 10. Gene expression data, as determined by qPCR assay, were normalized by using combined average dCt values of the two housekeeping genes: B2m and Rpl7 and then analyzed based on treatment, sex, and their interactions, and dam was the considered experimental unit for treatment effects. Number of replicates tested = seven female and seven male mice for CTL group, five female and five male mice for OXY group. Download Figure 10-1, TIF file.

Back to top

In this issue

eneuro: 8 (4)
eNeuro
Vol. 8, Issue 4
July/August 2021
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Maternal Oxycodone Treatment Results in Neurobehavioral Disruptions in Mice Offspring
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Maternal Oxycodone Treatment Results in Neurobehavioral Disruptions in Mice Offspring
Rachel E. Martin, Madison T. Green, Jessica A. Kinkade, Robert R. Schmidt, Tess E. Willemse, A. Katrin Schenk, Jiude Mao, Cheryl S. Rosenfeld
eNeuro 26 July 2021, 8 (4) ENEURO.0150-21.2021; DOI: 10.1523/ENEURO.0150-21.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Maternal Oxycodone Treatment Results in Neurobehavioral Disruptions in Mice Offspring
Rachel E. Martin, Madison T. Green, Jessica A. Kinkade, Robert R. Schmidt, Tess E. Willemse, A. Katrin Schenk, Jiude Mao, Cheryl S. Rosenfeld
eNeuro 26 July 2021, 8 (4) ENEURO.0150-21.2021; DOI: 10.1523/ENEURO.0150-21.2021
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • Analgesic
  • brain
  • DOHaD
  • drug abuse
  • gene expression
  • opioid

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Lactate receptor HCAR1 affects axonal development and contributes to lactate’s protection of axons and myelin in experimental neonatal hypoglycemia
  • Demyelination produces a shift in the population of cortical neurons that synapse with callosal oligodendrocyte progenitor cells
  • Caliber of Rohon-Beard touch-sensory axons is dynamic in vivo
Show more Research Article: New Research

Cognition and Behavior

  • Calcium Dynamics in Hypothalamic Paraventricular Oxytocin Neurons and Astrocytes Associated with Social and Stress Stimuli
  • Touchscreen Response Precision Is Sensitive to the Explore/Exploit Trade-off
  • Eye Movements in Silent Visual Speech Track Unheard Acoustic Signals and Relate to Hearing Experience
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.